Skin Disease in Korean Human Immunodeficiency Virus Patient
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: In Korea, new human immunodeficiency virus (HIV) patients continue to be diagnosed. Due to the development of highly active anti-retroviral therapy (HAART) and lengthening of survival period of infected person, the aspect of skin diseases of HIV-infected patients is also changing. Objective: To determine skin diseases of HIV-infected patients according to immune status and the relationship between folliculitis and HAART drug. Methods: Subjects were HIV-infected patients who were treated in the department of dermatology from September 1, 2008 to August 31, 2018. Medical records of 376 subjects were retrospectively analyzed. Results: Of 376 patients were studied, tinea infection, folliculitis, and seborrheic dermatitis were the most common regardless of their CD4 T cell counts or treatment group (initial treatment or retreatment). Seborrheic dermatitis, irritant contact dermatitis, and pruritic papular eruption were significantly more common in patients with CD4+T cells less than 200×106 cells/L while warts were significantly more frequent in patients with CD4+T cells greater than 200×106 cells/L. Most HAART agents were found to be helpful in reducing the incidence of folliculitis. Conclusion: There were many skin diseases in HIV patients, different from previous studies. In our study, the top three diagnoses were tinea infection, folliculitis, and seborrheic dermatitis. HAART medication was helpful in reducing folliculitis. These changes will require different treatments for skin diseases in HIV patients.
Abstract
Background: In Korea, new human immunodeficiency virus (HIV) patients continue to be diagnosed. Due to the development of highly active anti-retroviral therapy (HAART) and lengthening of survival period of infected person, the aspect of skin diseases of HIV-infected patients is also changing. Objective: To determine skin diseases of HIV-infected patients according to immune status and the relationship between folliculitis and HAART drug. Methods: Subjects were HIV-infected patients who were treated in the department of dermatology from September 1, 2008 to August 31, 2018. Medical records of 376 subjects were retrospectively analyzed. Results: Of 376 patients were studied, tinea infection, folliculitis, and seborrheic dermatitis were the most common regardless of their CD4 T cell counts or treatment group (initial treatment or retreatment). Seborrheic dermatitis, irritant contact dermatitis, and pruritic papular eruption were significantly more common in patients with CD4+T cells less than 200×106 cells/L while warts were significantly more frequent in patients with CD4+T cells greater than 200×106 cells/L. Most HAART agents were found to be helpful in reducing the incidence of folliculitis. Conclusion: There were many skin diseases in HIV patients, different from previous studies. In our study, the top three diagnoses were tinea infection, folliculitis, and seborrheic dermatitis. HAART medication was helpful in reducing folliculitis. These changes will require different treatments for skin diseases in HIV patients.
참고문헌 (16)
- 김민수, "사람면역결핍바이러스 감염인에서 CD4＋ T 림프구 수에 따른 피부질환", 대한피부과학회지, 51(10), pp.771~775 (2013), 대한피부과학회
- Bhatia MS, "A textbook on HIV infection and AIDS in adolescents", pp.1~26 (2008), New Age International
- Uthayakumar S, "The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression", Br J Dermatol, 137, pp.595~598 (1997)
- Tschachler E, "HIV-related skin diseases", Lancet, 348, pp.659~663 (1996)
- "Korea Federation for HIV/AIDS Prevention" (2019)[URL]
- Cedeno-Laurent F, "New insights into HIV-1-primary skin disorders", J Int AIDS Soc, 14, pp.5~ (2011)
- Kim TG, "Skin disorders in Korean patients infected with human immunodeficiency virus and their association with a CD4 lymphocyte count : a preliminary study", J Eur Acad Dermatol Venereol, 24, pp.1476~1480 (2010)
- Scott C, "Acne vulgaris and acne rosacea as part of immune reconstitution disease in HIV-1 infected patients starting antiretroviral therapy", Int J STD AIDS, 19, pp.493~495 (2008)
- Haddow LJ, "Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa", PLoS One, 7, pp.e40623~ (2012)
- Annam V, "Clinicopathological study of itchy folliculitis in HIV-infected patients", Indian J Dermatol Venereol Leprol, 76, pp.259~262 (2010)
- Farsani TT, "Etiology and risk factors associated with a pruritic papular eruption in people living with HIV in India", J Int AIDS Soc, 16, pp.17325~ (2013)
- Afonso JP, "Pruritic popular eruption and eosinophilic folliculitis associated with human immunodeficiency virus(HIV)infection : a histopathological and immunohistochemical comparative study", J Am Acad Dermatol, 67, pp.269~275 (2012)
- Okada S, "Immunosuppression-associated eosinophilic pustular folliculitis(IS-EPF)developing after Highly Active Anti-Retroviral Therapy(HAART) : the possible mechanisms through CD163+ M2 macrophages", Eur J Dermatol, 23, pp.713~714 (2013)
- Cha SH, "Chronic recurrent folliculitis with atypical hyperpigmented scarring in an AIDS patient", Ann Dermatol, 11, pp.55~58 (1999)
- 신봉석, "A Case of Human Immunodeficiency Virus Infection Initially Presented with Disseminated Herpes Zoster", Annals of Dermatology, 22(2), pp.199~202 (2010), 대한피부과학회
- Lee DK, "A case of AIDS-related Kaposi's sarcoma", Ann Dermatol, 12, pp.211~214 (2000)